OR
SGEN

Olympiad Research’s Seagen Inc. Common Stock SGEN Stock Holding History

Olympiad Research’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,923
Closed -$1.47M – 461
2023
Q3 		$1.47M Buy
6,923
+2,048
+42% +$409K 1.44% 7
2023
Q2 		$938K Buy
4,875
+2,381
+95% +$473K 0.92% 18
2023
Q1 		$505K Buy
+2,494
New +$400K 0.59% 33
2022
Q3 		$228K Buy
+1,664
New +$271K 0.12% 187

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Olympiad Research's SGEN Position: Q4 2023 in Review

Olympiad Research sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 6,923 shares — an estimated $1.47M sold.

Olympiad Research first reported a position in SGEN in Q3 2022 and held it in 4 quarters. The position peaked at $1.47M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Olympiad Research reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Olympiad Research sold 6,923 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.47M.
  • Olympiad Research first reported a position in Seagen Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Olympiad Research's Seagen Inc. Common Stock position peaked at $1.47M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Olympiad Research's 13F filing for Q4 2023, filed 12 Feb 2024.